MarketCap
Facebook
X
TelegramQuartalsbericht 2022-Q3
hinzugefügt 21.11.2022
Applied Genetic Technologies Corporation ROE 2011-2026 | AGTC
ROE Jährlich Applied Genetic Technologies Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -62.37 | -22.31 | -21.77 | -2.55 | -21.48 | 0.35 | -1.26 | -28.43 | -21.25 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 0.35 | -62.37 | -20.12 |
ROE Vierteljährlich Applied Genetic Technologies Corporation
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -165.12 | -202.3 | -92.2 | -129.38 | -123.61 | -123.66 | -136.28 | -136.34 | -139.08 | -116.2 | -93.33 | -70.45 | -60.12 | -51.26 | -42.4 | -33.54 | -14.99 | -14.14 | -9.84 | -8.99 | -11.72 | -5.56 | -1.71 | 4.85 | 9.37 | 10.85 | -1.16 | 0.49 | -13.49 | -21.21 | -17.12 | -26.89 | -23.41 | 0.85 | 25.65 | 35.81 | 23.47 | 23.47 | 3.95 | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 35.81 | -202.3 | -44.79 |
ROE anderer Aktien in der Pharmaeinzelhändler
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Acer Therapeutics
ACER
|
156.54 | - | 2.71 % | $ 14 M |  USA |
 |
MorphoSys AG
MOR
|
15.76 | - | 2.43 % | $ 254 M |  Germany |
 |
Adaptimmune Therapeutics plc
ADAP
|
-288.19 | - | -15.15 % | $ 60.3 M |  Britain |
 |
Adverum Biotechnologies
ADVM
|
-185.15 | - | - | $ 86.2 M | USA |
 |
ANI Pharmaceuticals
ANIP
|
-4.59 | $ 80.34 | -1.83 % | $ 1.55 B | USA |
 |
Aptorum Group Limited
APM
|
-20.19 | $ 0.84 | 3.54 % | $ 4.58 M |  China |
 |
Acasti Pharma
ACST
|
-14.36 | - | 4.01 % | $ 150 M |  Canada |
 |
I-Mab
IMAB
|
-85.31 | - | - | $ 866 M | China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.18 | - | - | $ 40.3 B | USA |
 |
Adagene
ADAG
|
-66.16 | $ 2.67 | 1.52 % | $ 150 M | China |
 |
Biophytis SA
BPTS
|
-751.94 | - | -13.47 % | $ 169 M |  France |
 |
AlloVir
ALVR
|
-51.87 | - | 4.14 % | $ 49.1 M | USA |
 |
Midatech Pharma plc
MTP
|
-330.29 | - | -18.52 % | $ 27.3 M | Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-115.61 | - | -1.52 % | $ 24.7 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-256.9 | - | -11.43 % | $ 502 K | USA |
 |
Alterity Therapeutics Limited
ATHE
|
-36.22 | $ 3.57 | 1.13 % | $ 8.59 B |  Australia |
 |
Applied Molecular Transport
AMTI
|
-207.64 | - | - | $ 10.1 M | USA |
 |
ARCA biopharma
ABIO
|
-21.9 | - | 1052.0 % | $ 415 M | USA |
 |
BioNTech SE
BNTX
|
1.11 | $ 110.34 | 3.49 % | $ 27.2 B | Germany |
 |
Acorda Therapeutics
ACOR
|
160.08 | - | -24.86 % | $ 820 K | USA |
 |
Cabaletta Bio
CABA
|
-28.65 | $ 2.44 | -2.79 % | $ 2.85 M | USA |
 |
Akero Therapeutics
AKRO
|
-33.6 | - | - | $ 3.67 B | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-144.96 | $ 4.22 | 1.44 % | $ 9.18 B |  Israel |
 |
Aeglea BioTherapeutics
AGLE
|
-40.17 | - | - | $ 1.01 B | USA |
 |
Akebia Therapeutics
AKBA
|
169.78 | $ 1.5 | 7.91 % | $ 281 M | USA |
 |
Aptose Biosciences
APTO
|
559.76 | - | -45.71 % | $ 1.2 M | Canada |
 |
Albireo Pharma
ALBO
|
-19.38 | - | -0.23 % | $ 916 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - |  Russia |
 |
Ascendis Pharma A/S
ASND
|
-43.41 | $ 222.03 | -0.05 % | $ 5 B |  Danmark |
 |
Allena Pharmaceuticals
ALNA
|
-257.91 | - | 3.16 % | $ 1.9 M | USA |
 |
Compugen Ltd.
CGEN
|
-25.92 | $ 1.71 | 2.4 % | $ 153 M | Israel |
 |
Aptinyx
APTX
|
-169.38 | - | -39.0 % | $ 4.57 M | USA |
 |
Aravive
ARAV
|
-716.17 | - | -13.39 % | $ 1.45 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
-91.56 | - | -6.81 % | $ 3.04 B | USA |
 |
Burford Capital Limited
BUR
|
10.1 | $ 8.97 | 0.56 % | $ 1.43 B | Britain |
 |
Aridis Pharmaceuticals
ARDS
|
125.33 | - | 17.91 % | $ 11.1 M | USA |
 |
Aeterna Zentaris
AEZS
|
-401.79 | - | 5.93 % | $ 314 M | Canada |
 |
Corcept Therapeutics Incorporated
CORT
|
20.78 | $ 41.31 | 1.18 % | $ 4.26 B | USA |
 |
AgeX Therapeutics
AGE
|
-270.67 | - | -10.17 % | $ 12.2 K | USA |
 |
Athira Pharma
ATHA
|
-216.19 | - | - | $ 269 M | USA |
 |
Athersys
ATHX
|
-531.22 | - | 3.77 % | $ 22.4 M | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
22.52 | $ 24.45 | 0.04 % | $ 2.9 B | USA |
 |
Cardiff Oncology
CRDF
|
-54.77 | $ 1.58 | -1.25 % | $ 75.3 M | USA |
 |
Akouos
AKUS
|
-37.09 | - | 0.23 % | $ 488 M | USA |
 |
CRISPR Therapeutics AG
CRSP
|
-18.96 | $ 49.7 | 1.97 % | $ 4.19 B |  Schweiz |
|
Champions Oncology
CSBR
|
124.63 | $ 6.55 | - | $ 89.5 M | USA |
 |
Avenue Therapeutics
ATXI
|
-418.16 | - | -52.27 % | $ 4.45 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
-51.64 | $ 1.46 | 2.82 % | $ 373 M | Britain |
 |
Amneal Pharmaceuticals
AMRX
|
67.61 | $ 14.52 | - | $ 4.49 B | USA |